Nationwide Fund Advisors’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-25,219
Closed -$1.57M 1701
2017
Q3
$1.57M Sell
25,219
-447
-2% -$27.8K 0.01% 1554
2017
Q2
$2.04M Buy
25,666
+1,860
+8% +$148K 0.01% 1420
2017
Q1
$1.69M Sell
23,806
-6,910
-22% -$491K 0.01% 1483
2016
Q4
$1.57M Buy
30,716
+66
+0.2% +$3.37K 0.01% 1531
2016
Q3
$1.41M Buy
30,650
+1,650
+6% +$76K 0.01% 1576
2016
Q2
$874K Buy
29,000
+6,808
+31% +$205K ﹤0.01% 1814
2016
Q1
$711K Buy
22,192
+1,049
+5% +$33.6K ﹤0.01% 1891
2015
Q4
$1.23M Buy
21,143
+1,816
+9% +$106K 0.01% 1616
2015
Q3
$818K Sell
19,327
-1,600
-8% -$67.7K ﹤0.01% 1829
2015
Q2
$1.53M Sell
20,927
-4,114
-16% -$300K 0.01% 1600
2015
Q1
$1.26M Buy
25,041
+903
+4% +$45.4K 0.01% 1772
2014
Q4
$883K Buy
24,138
+18,947
+365% +$693K ﹤0.01% 1873
2014
Q3
$164K Buy
+5,191
New +$164K ﹤0.01% 2793